Learn from experienced investors how to best position your company for funding in today’s recovering economy. Panelists discuss funding opportunities for every stage of financing, including government sources relevant to emerging technology companies.
Moderator:
- Adam C. Lenain, Partner, Foley & Lardner LLP
Panelists:
- Tina Huth, MBA, Managing Director, R&D Business Solutions, LLC
- Scott L. Klug, Public Affairs Director, Foley & Lardner LLP
- Arama Kukutai, Managing Director, Finistere Ventures, LLC
- Terry W. Moore, MBA, Managing Partner, Moore Venture Partners, LP
Related Insights
20 December 2024
Health Care Law Today
GLP-1 Drugs: FDA “Re-Confirms” Decision Removing Tirzepatide from the Drug Shortage List
On December 19, 2024, the U.S. Food and Drug Administration (FDA) issued a Declaratory Order reevaluating and re-confirming that the tirzepatide drug shortage has been resolved. This order revoked and replaced FDA’s October 2, 2024, decision on tirzepatide.
20 December 2024
Manufacturing Industry Advisor
Christmas Came Early: Justice Delivered in Supplier Dispute Over Unjust Enrichment
The AirBoss saga continues… This holiday season, AirBoss Flexible Products Co. received a monumental legal victory, righting a costly wrong in MSSC, Inc. v. AirBoss.
19 December 2024
Health Care Law Today
HIPAA Reproductive Health Care Amendments: Compliance in an Uncertain Enforcement Landscape
The amendments to the HIPAA Privacy Rule designed to protect reproductive health care information are under legal challenge as the compliance date quickly approaches.